GleamWall
中文EN

ELTX Elicio Therapeutics, Inc.

Pharmaceutical Preparations · Nasdaq · SEC CIK 1601485 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY22.1%
TTM EPS YoY41.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-315.3%
ROA-105.3%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets52.4%
Debt / equity0.51x
Current ratio3.43x
Interest coverage-24.46x

Cash quality & payout

Operating cash flow / net income1.03x
Accruals ratio3.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$24.90M$33.66M
SG&A expense$12.81M$11.33M
Operating income-$37.71M-$44.99M
Interest expense$1.13M$455,000
Pretax income-$39.57M-$51.90M
Income tax$0$0
Net income-$39.57M-$51.90M
EBITDA-$37.51M-$44.66M
EPS (basic)-2.58-4.25
EPS (diluted)-2.58-4.25
Weighted avg. shares (diluted)15.31M12.20M
Balance sheet
Cash & equivalents$18.56M$19.49M
Current assets$19.31M$20.69M
PP&E, net$295,000$483,000
Total assets$25.86M$28.18M
Current liabilities$8.11M$11.52M
Short-term debt$0—
Long-term debt$9.41M$20.03M
Total debt$9.41M$20.03M
Total liabilities$24.23M$39.49M
Shareholders' equity$1.64M-$11.31M
Net debt-$9.16M$542,000
Shares outstanding17.80M11.03M
Cash flow statement
Operating cash flow-$36.95M-$37.07M
Capital expenditure$16,000$87,000
Free cash flow-$36.97M-$37.16M
Investing cash flow-$16,000-$84,000
Financing cash flow$36.70M$42.32M
Depreciation & amortization$204,000$321,000
Stock-based compensation$2.70M$1.45M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.